氯胺酮给药后癫痫持续状态缓解
本文报告1例9月龄女婴,到达急诊前持续右侧上下肢抽搐45分钟,先后接受直肠地西泮、肌注咪达唑仑、2剂劳拉西泮、左乙拉西坦、磷苯妥英及另2剂劳拉西泮后发作仍难治且全面化。因预期插管且基于氯胺酮对NMDA受体的作用,给予氯胺酮1 mg/kg静脉注射,阵挛性运动和眼偏斜停止,随后插管、丙泊酚镇静并收入PICU,脑电图未见癫痫波形。作者指出氯胺酮理论上通过阻断癫痫持续状态中上调的NMDA受体中止发作,目前尚无随机对照试验,作者认为氯胺酮可能用于癫痫持续状态,可考虑用于快速序贯插管诱导,并可能作为难治性病例的三线或四线药物。
要点
- 9月龄女婴持续右侧上下肢抽搐45分钟,经直肠地西泮、肌注咪达唑仑、2剂劳拉西泮、左乙拉西坦、磷苯妥英及另2剂劳拉泮后仍难治且全面化。
- 因预期插管并基于氯胺酮对NMDA受体的作用,给予氯胺酮1 mg/kg静脉注射后阵挛性运动和眼偏斜停止,随后插管、丙泊酚镇静收入PICU,脑电图未见癫痫波形。
- 作者认为氯胺酮可能对癫痫持续状态有作用,可考虑用于快速序贯插管诱导,并可能作为难治性病例的三线或四线药物。
- 作者指出氯胺酮理论上通过阻断癫痫持续状态中上调的NMDA受体中止发作,迄今尚无随机对照试验。
- 出院1周后复查患儿恢复至基线水平;实验室检查除WBC 24.5、血糖346、CO2 17且阴离子间隙正常外无异常,尿检提示尿路感染。
适用人群与场景
- 儿童癫痫持续状态患者,本文为9月龄女婴,到达急诊前持续右侧上下肢抽搐45分钟。
处置流程与药物剂量
- 按现有流程先予苯二氮䓬类一线治疗,随后左乙拉西坦或丙戊酸,可能磷苯妥英,最终大剂量丙泊酚和插管。
- 本病例在多种抗癫痫药无效后,因预期插管并基于氯胺酮对NMDA受体的作用,给予氯胺酮1 mg/kg静脉注射。
- 发作停止后插管保护气道,丙泊酚镇静,收入PICU。
红旗征与不能漏的情况
- 持续右侧上下肢抽搐45分钟,经直肠地西泮、肌注咪达唑仑、2剂劳拉西泮、左乙拉西坦、磷苯妥英及另2剂劳拉西泮后发作仍难治且全面化。
研究设计与关键结果
- 病例报告:9月龄女婴,持续右侧上下肢抽搐45分钟,先后接受直肠地西泮、肌注咪达唑仑、2剂劳拉西泮、左乙拉西坦、磷苯妥英及另2剂劳拉西泮后发作仍难治且全面化。
- 给予氯胺酮1 mg/kg静脉注射后阵挛性运动和眼偏斜停止,随后插管、丙泊酚镇静收入PICU,脑电图未见癫痫波形。
- 实验室检查除WBC 24.5、血糖346、CO2 17且阴离子间隙正常外无异常,尿检提示尿路感染;出院1周后复查恢复至基线。
证据类型、等级与局限
- 证据类型:病例报告。
- 作者指出氯胺酮理论上通过阻断癫痫持续状态中上调的NMDA受体中止发作,迄今尚无随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为氯胺酮可能对癫痫持续状态有作用,可考虑用于快速序贯插管诱导,并可能作为难治性病例的三线或四线药物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Status Epilepticus is the most common non-traumatic neurologic emergency in childhood. Current algorithms prioritize the use of benzodiazepines as first line treatment followed by Levetiracetam or Valproic Acid, possibly Fosphenytoin and eventually high dose Propofol and intubation.
CASE REPORT: A 9-month old girl was brought to the emergency department with a continuous seizure involving the right upper and lower extremity for 45 min prior to arrival. Patient received a dose of rectal Diazepam, intramuscular Midazolam, 2 doses of Lorazepam, Levetiracetam, Fosphenytoin and 2 additional doses of Lorazepam. The seizure remained refractory and generalized. In anticipation of intubation, and because of its action on the NMDA receptor, Ketamine (1 mg/kg IV) was administered. The clonic movements and eye deviations stopped. Patient was intubated for airway protection, sedated with Propofol, then admitted to the PICU. EEG showed no evidence of a seizure pattern. Labs (CBC, CMP, COVID) were unremarkable except for WBC 24.5, blood glucose of 346 and CO2 of 17 with normal anion gap. Urinalysis showed a urinary tract infection. Patient was at her baseline on 1 week post-discharge re-evaluation. Ketamine theoretically may abort seizures through blockade of NMDA receptors which are unregulated in status epilepticus. To date, no randomized controlled trials have been reported. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Ketamine may have a role in treating status epilepticus. It may be considered for induction for rapid sequence intubation and possibly as a third or fourth line agent in refractory cases.
参考来源
- Howing CE, Razi F, Hakmeh W, et al. Resolution of status epilepticus after ketamine administration. Am J Emerg Med. 2021. PMID: 34763960. doi:10.1016/j.ajem.2021.10.052
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。